Femoxetine and eye function. A study of possible anticholinergic side effects. 1985

K V Jeppesen, and H C Fledelius

A pilot study of the possible anticholinergic side effects of femoxetine comprised eight depressive patients (age 42-65), followed up for a month, and five healthy volunteers (age 26-39), who received medication for a week. As judged primarily from ophthalmic parameters (accomodation, lacrimation, pupil size, intraocular pressure, exe motility, visual acuity and visual fields, slit lamp examination and ophthalmoscopy), there was no indication of anticholinergic side effects of the drug. According to Schirmer-1-test (tear wetting), the rather dry eyes of depressive patients even improved somewhat during medication.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010880 Piperidines A family of hexahydropyridines.
D005128 Eye Diseases Diseases affecting the eye. Eye Disorders,Eye Disease,Eye Disorder
D005260 Female Females
D005901 Glaucoma An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed) Glaucomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant

Related Publications

K V Jeppesen, and H C Fledelius
January 2004, Primary care companion to the Journal of clinical psychiatry,
K V Jeppesen, and H C Fledelius
August 2000, Allergy,
K V Jeppesen, and H C Fledelius
September 2022, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie,
K V Jeppesen, and H C Fledelius
December 1989, Southern medical journal,
K V Jeppesen, and H C Fledelius
April 1988, Annals of neurology,
K V Jeppesen, and H C Fledelius
August 2000, Primary care companion to the Journal of clinical psychiatry,
K V Jeppesen, and H C Fledelius
February 1980, The Journal of clinical psychiatry,
K V Jeppesen, and H C Fledelius
August 2019, European geriatric medicine,
K V Jeppesen, and H C Fledelius
January 1988, Progress in neuro-psychopharmacology & biological psychiatry,
K V Jeppesen, and H C Fledelius
September 2000, Journal of the Royal Society of Medicine,
Copied contents to your clipboard!